Dr. Beatrice Setnik Honored as PharmaVoice 100 Winner
Altasciences is thrilled to share that Dr. Beatrice Setnik has been honored as a PharmaVoice 100 winner. With almost two decades of expertise in clinical drug development, especially regarding abuse potential studies, Dr. Setnik's leadership qualities have made a notable impact in the field. As the Chief Scientific Officer (CSO) at Altasciences, she also contributes to the educational sector as an adjunct professor at the University of Toronto and is actively involved in developing programs for children.
Recognizing Contributions to Life Sciences
In an exclusive interview with PharmaVoice, Dr. Setnik's significant contributions to life sciences were highlighted. Each PharmaVoice 100 honoree undergoes rigorous evaluation by the PharmaVoice team, categorized into diverse groups including Standout Leaders, Cancer Care Visionaries, and Tech and AI Wizards, among others. Each individual's unique achievements reflect the transformative power of the pharmaceutical industry.
Dr. Setnik's Inspiring Journey
Dr. Setnik expressed her gratitude saying, "Thank you very much to PharmaVoice for this honor, which would have been impossible without the support of my colleagues, the clients at Altasciences, and of course, my peers and collaborators over the years.” Such recognition among incredible innovators and trailblazers is indeed humbling.
The Impact of PharmaVoice 100
Since its inception in 2005, the PharmaVoice 100 has been a coveted feature, celebrating distinguished individuals across all sectors of life sciences. From academics and nonprofits to startups and large pharmaceutical companies, the program stands out in honoring meaningful contributions toward advancing patient health globally.
About Altasciences and Its Goals
Altasciences is a comprehensive drug development company that provides a flexible approach to pharmaceutical and biotechnology firms aiming to enhance drug development. With over 25 years of experience, Altasciences emphasizes effective decision-making through preclinical and clinical pharmacology studies, ensuring that the best possible medicines reach those in need in a timely manner. Their services span across formulation, manufacturing, and analytical services, thorough preclinical safety evaluations, and proof of concept studies.
Dr. Setnik's Advancements in Drug Development
Since taking on the role of CSO in 2019, Dr. Setnik’s leadership has sparked innovative clinical methods for studying new compounds safely during early-phase drug development. Her acclaimed work has not only garnered recognition as a “Scientific Trailblazer” but has also earned her a spot among the 30 Most Influential People in the Pharma Industry.
A Bright Future Ahead
Meagan Parrish, the Lead Editor of PharmaVoice, remarked, “These honorees inspire their teams, offering guidance and support to their patients while propelling their organizations toward excellence.” The impact of these award winners marks a significant stride toward a healthier future for societies globally.
Frequently Asked Questions
What is the PharmaVoice 100?
The PharmaVoice 100 is an annual recognition program that celebrates impactful individuals in the life sciences sector across various categories.
Who is Dr. Beatrice Setnik?
Dr. Beatrice Setnik is the Chief Scientific Officer at Altasciences, recognized for her extensive experience in clinical drug development and her educational contributions.
What does Altasciences do?
Altasciences provides integrated drug development solutions, offering services from preclinical research to clinical pharmacology studies aimed at drug development efficiencies.
What was Dr. Setnik's reaction to the honor?
Dr. Setnik expressed tremendous gratitude for the honor, highlighting the vital support from her colleagues and clients at Altasciences.
Why are achievements in pharma important?
Achievements in the pharmaceutical industry are essential for developing medications that improve patient outcomes and advance healthcare globally.
